Related Experiment Videos

[The predictive value of serum advanced fibrinogen and uric acid for acute coronary event risk]

Mei-yan Liu1, Da-yi Hu

  • 1Department of Cardiology, Beijing University People's Hospital, Beijing 100044, China.

Insights

Serum fibrinogen (FIB) predicts acute coronary events, while uric acid (UA) does not independently. High levels of both FIB and UA significantly increase acute coronary event risk, suggesting their combined use for risk prediction.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Clinical Diagnostics

Context:

  • Acute coronary events, including myocardial infarction and unstable angina, pose significant health risks.
  • Accurate prediction of acute coronary events is crucial for timely intervention and management.
  • Biomarkers such as fibrinogen and uric acid are being investigated for their role in cardiovascular risk assessment.

Purpose:

  • To investigate the predictive value of serum advanced fibrinogen (FIB) and uric acid (UA) levels for acute coronary events.
  • To determine if FIB and UA are independent risk factors for acute coronary events.
  • To explore the combined effect of FIB and UA on acute coronary event risk.

Summary:

  • Serum FIB levels were significantly higher in patients with acute coronary events compared to controls.
  • Serum UA levels did not show a significant difference between groups and was not an independent risk factor.
  • Multivariate analysis indicated FIB as a significant predictor, and high levels of both FIB and UA jointly increased acute coronary event risk.

Impact:

  • Findings suggest that serum FIB is a valuable predictor of acute coronary events.
  • The combined assessment of FIB and UA may enhance the prediction of acute coronary risk.
  • This research contributes to understanding the role of specific biomarkers in atherosclerosis and cardiovascular disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...